Concepedia

Robert Casella

RC

6

Publications

326

Citations

6

H-Index

1998

Active since

Affiliations

AstraZeneca (United States)(Current)

Massachusetts College of Pharmacy and Health Sciences

AstraZeneca (United Kingdom)

Wilmington University

Robert Casella is an author at AstraZeneca (United States) specializing in biomolecular engineering, inorganic chemistry, and organic chemistry.

Top concepts

Publications per year

1998–2025

6

Publications

6

Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies

Bernard Barlaam, Robert Casella, Justin Cidado et al. · Journal of Medicinal Chemistry · 2020 · 98 citations · Full text

The physicochemical characteristics and bioavailability of indomethacin from β-cyclodextrin, hydroxyethyl-β-cyclodextrin, and hydroxypropyl-β-cyclodextrin complexes

Sunil S. Jambhekar, Robert Casella, T. Maher · International Journal of Pharmaceutics · 2003 · 89 citations

, , +5

Pyrimidinone Nicotinamide Mimetics as Selective Tankyrase and Wnt Pathway Inhibitors Suitable for in Vivo Pharmacology

Jeffrey W. Johannes, Lynsie Almeida, Bernard Barlaam et al. · ACS Medicinal Chemistry Letters · 2015 · 64 citations · Full text

, , +18

Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water. I. Formation studies

Robert Casella, David A. Williams, Sunil S. Jambhekar · International Journal of Pharmaceutics · 1998 · 36 citations

, , +7

Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water. II. Solubility studies

Robert Casella, David A. Williams, Sunil S. Jambhekar · International Journal of Pharmaceutics · 1998 · 24 citations

, , +6

Rows per page

1–5 of 6